↓ Skip to main content

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
81 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
40 Mendeley
Title
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer
Published in
JAMA Oncology, September 2021
DOI 10.1001/jamaoncol.2021.2318
Pubmed ID
Authors

Heath Skinner, Chen Hu, Theodoros Tsakiridis, Rafael Santana-Davila, Bo Lu, Jeremy J. Erasmus, Anthony J. Doemer, Gregory M. M. Videtic, James Coster, Alex Xuezhong Yang, Richard Y. Lee, Maria Werner-Wasik, Philip E. Schaner, Steven E. McCormack, Benjamin T. Esparaz, Ronald C. McGarry, Jose Bazan, Timothy Struve, Rebecca Paulus, Jeffrey D. Bradley

X Demographics

X Demographics

The data shown below were collected from the profiles of 81 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 10%
Student > Ph. D. Student 3 8%
Other 2 5%
Researcher 2 5%
Student > Bachelor 1 3%
Other 2 5%
Unknown 26 65%
Readers by discipline Count As %
Medicine and Dentistry 6 15%
Nursing and Health Professions 5 13%
Biochemistry, Genetics and Molecular Biology 3 8%
Sports and Recreations 1 3%
Unknown 25 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 101. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#401,294
of 24,788,795 outputs
Outputs from JAMA Oncology
#673
of 3,224 outputs
Outputs of similar age
#10,051
of 422,275 outputs
Outputs of similar age from JAMA Oncology
#19
of 92 outputs
Altmetric has tracked 24,788,795 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,224 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.